Summary
Definition
History and exam
Key diagnostic factors
- ასაკი < 2 წ
- იმუნოსუპრესია
- მაღალი ცხელება
- ეგზანთემა
Other diagnostic factors
- დიარეა
- მუცლის ტკივილი
- ნაგაიამას ლაქები
- დაფის აპკის ანთება
- ზედა სასუნთქი გზების სიმპტომები
- გულყრები
- პერიორბიტული ედემა
- წინა ყიფლიბადის გამობერილობა
- კისრის, კეფის და ყურის უკანა ლიმფადენოპათია
Risk factors
- ასაკი < 2 წ
- იმუნოსუპრესია
Diagnostic tests
1st tests to order
- საწყისი ტესტის არარსებობა
Tests to consider
- ვირუსული კულტურა
- ანტისხეულის აღმოჩენა
Emerging tests
- პოლიმერაზული ჯაჭვური რეაქცია (PCR)
- იმუნოჰისტოქიმია
Treatment algorithm
ყველა პაციენტის
Contributors
Authors
Henry M. Feder, Jr., MD
Professor of Pediatrics and Family Medicine
University of Connecticut Medical Center and Connecticut Children’s Medical Center
Farmington
CT
Disclosures
HMF declares that he has no competing interests.
Hassan El Chebib, MD
Attending Physician in the Division of Infectious Diseases and Immunology
Connecticut Children’s Medical Center
Assistant Professor of Pediatrics
Pediatrics, Infectious Diseases and Immunology
University of Connecticut School of Medicine
Hartford
CT
Disclosures
HEC declares that he has no competing interests.
Ashley C. Howard, DO
Attending Physician in the Division of Infectious Diseases and Immunology
Connecticut Children’s Medical Center
Assistant Professor of Pediatrics
Pediatrics, Infectious Diseases and Immunology
University of Connecticut School of Medicine
Hartford
CT
Disclosures
ACH declares that she has no competing interests.
Acknowledgements
Dr Henry M. Feder, Dr Hassan El Chebib, and Dr Ashley C. Howard would like to gratefully acknowledge Dr Edward C. Kim, Dr Nicholas Bennett, Dr James Azim, Dr Margie C. Andreae, Dr Jon Dyer, and Dr Jennifer Holman, the previous contributors to this topic.
Disclosures
ECK, NB, JA, MCA, JD, and JH declare that they have no competing interests.
Peer reviewers
Helen Goodyear, MBChB, MRCP, FRCPCH, MD, MMed
Consultant Paediatrician
Heartlands Hospital
Birmingham
UK
Disclosures
HG declares that she has no competing interests.
Mary T. Caserta, MD
Associate Professor of Pediatrics
Department of Pediatrics
Division of Infectious Diseases
University of Rochester Medical Center
Rochester
NY
Disclosures
MTC declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
References
Key articles
Kimberlin DW, Barnett ED, Lynfield R, et al. Human herpesvirus 6 (including roseola) and 7. In: Red Book: 2021–2024 report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.
Braun DK, Dominguez G, Pellett PE. Human herpesvirus 6. Clin Microbiol Rev. 1997;10:521-67.Full text Abstract
Hall CB, Long CE, Schnabel KC, et al. Human herpesvirus-6 infection in children: a prospective study of complications and reactivation. N Engl J Med. 1994 Aug 18;331(7):432-8.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Differentials
- წითელა
- ენტეროვირუსი
- ეპშტეინ-ბარის ვირუსი
More DifferentialsGuidelines
- Viral exanthems
- Human herpesvirus 6 (including roseola) and 7
More Guidelines
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer